Boston Scientific and Heartflow Partner on CT-Guided PCI Planning

Boston Scientific and Heartflow have announced a strategic collaboration focused on CT-guided planning for percutaneous coronary intervention (PCI) in patients with coronary artery disease. Medical Product Outsourcing reported that the companies will evaluate compatibility between Heartflow’s AI-powered PCI Navigator platform and Boston Scientific’s AVVIGO+ multi-modality guidance system.

Collaboration centers on procedural planning and guidance

According to Medical Product Outsourcing, Heartflow’s PCI Navigator creates patient-specific 3D coronary models for preprocedural planning. The planned compatibility evaluation pairs that planning capability with Boston Scientific’s AVVIGO+ system, which supports intravascular imaging.

The announcement places CT-guided planning and intravascular guidance in the same collaboration framework for PCI. The companies described the work as an effort to advance CT-guided planning for procedures involving patients with coronary artery disease.

What medical-device sales teams should note

For sales professionals working in coronary intervention, the collaboration highlights the continued attention on connected procedural workflows. The technologies named in the announcement address different points in the PCI process: patient-specific coronary modeling before the procedure and multi-modality guidance with intravascular imaging support.

Medical Product Outsourcing identified the compatibility assessment as the next stated activity in the partnership. Sales conversations around the announcement can remain grounded in the companies’ stated focus: evaluating how Heartflow’s AI-powered PCI Navigator platform may align with Boston Scientific’s AVVIGO+ multi-modality guidance system.

Named technologies

• Heartflow PCI Navigator: an AI-powered platform that creates patient-specific 3D coronary models for preprocedural planning.
• Boston Scientific AVVIGO+: a multi-modality guidance system that supports intravascular imaging.

The companies’ announcement does not describe results from the compatibility evaluation. Medical Product Outsourcing characterized the arrangement as a strategic collaboration to advance CT-guided PCI planning.